Page last updated: 2024-08-21

gamma-thiobutyrolactone and Kidney Failure, Chronic

gamma-thiobutyrolactone has been researched along with Kidney Failure, Chronic in 1 studies

*Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
El-Fattah, MA; Khan, JA; Zohny, SF1

Other Studies

1 other study(ies) available for gamma-thiobutyrolactone and Kidney Failure, Chronic

ArticleYear
Circulating Fibroblast Growth Factor-23 Level and Paraoxonase-1 Lactonase Activity in Chronic Hemodialysis Patients: Their Impact on the Incidence of Native AV Fistula Thrombosis.
    Clinical and investigative medicine. Medecine clinique et experimentale, 2016, Oct-14, Volume: 39, Issue:5

    Topics: 4-Butyrolactone; Adult; Aged; Arteriovenous Fistula; Aryldialkylphosphatase; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Thrombosis

2016